Les résultats et les conclusions des travaux menés par l’écosystème Experts Recherche Lymphome sont publiés dans des journaux médicaux de premier plan.
Lysa
2021_LYSA_Sub-Cutaneous Rituximab-MiniCHOP compared to Sub-Cutaneous Rituximab-MiniCHOP plus Lenalidomide in Diffuse Large B Cell Lymphoma for Patients of 80 Years or older.
J Clin Oncol . 2021 Apr 10;39(11):1203-1213. doi: 10.1200/JCO.20.02666.
En savoir plus
Lysa
2021_LYSA_A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the « REal world dAta in LYmphoma and survival in adults » (REALYSA) cohort
BMC Public Health . 2021 Mar 2;21(1):432. doi: 10.1186/s12889-021-10433-4.
En savoir plus
Lysa
2021_LYSA_Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lyphoma: a phase 1/2 trial
Blood . 2021 Feb 18;137(7):877-887. doi: 10.1182/blood.2020008727.
En savoir plus
Lysa
2021_LYSA_BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres
Br J Haematol . 2021 Feb;192(3):e94-e98. doi: 10.1111/bjh.17279.
En savoir plus
Lysa
2021_LYSA_Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
Blood Adv . 2021 Jan 26;5(2):539-548. doi: 10.1182/bloodadvances.2020003081.
En savoir plus
Lysa
2021_LYSA_Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Leukemia . 2021 Jan;35(1):143-155. doi: 10.1038/s41375-020-0838-5
En savoir plus
Lysa
2021_LYSA_Combining Brentuximab Vedotin With Dexamethasone, High-Dose Cytarabine and Cisplatin as Salvage Treatment in Relapsed or Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE Study
Haematologica . 2021 Apr 1;106(4):1129-1137.
En savoir plus
Lysa
2021_LYSA_A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer . 2021 Dec;108(12S):S82-S86.
En savoir plus
Lysa
2021_LYSA_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma
Front Immunol . 2021 Dec 16;12:755623.
En savoir plus
Lysa
2021_LYSA_Current Role of Functional Imaging in the Management of Lymphoma
Curr Oncol Rep . 2021 Nov 4;23(12):144.
En savoir plus
Lysa
2021_LYSA_Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma
Eur J Cancer . 2021 Nov;157:132-139.
En savoir plus
Lysa
2021_LYSA_FDG-PET/CT in Lymphoma: Where Do We Go Now?
Cancers (Basel) . 2021 Oct 18;13(20):5222.
En savoir plus
Lysa
2021_LYSA_DESCAR-T, le registre national des patients traités par CAR-T Cells
Bull Cancer . 2021 Oct;108(10S):S143-S154.
En savoir plus
Lysa
2021_LYSA_Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacy
Expert Rev Anticancer Ther . 2021 Sep;21(9):941-956.
En savoir plus
Lysa
2021_LYSA_Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial
Lancet Haematol . 2021 Sep;8(9):e648-e657.
En savoir plus
Lysa
2021_LYSA_Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
Nat Commun . 2021 Sep 22;12(1):5577.
En savoir plus
Lysa
2021_LYSA_Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
Cancers (Basel) . 2021 Sep 7;13(18):4503.
En savoir plus
Lysa
2021_LYSA_Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy
Am J Hematol . 2021 Aug 1;96(8):934-944. doi: 10.1002/ajh.26209.
En savoir plus
Lysa
2021_LYSA_Total tumor burden in lymphoma – an evolving strong prognostic parameter
Br J Radiol . 2021 Nov 1;94(1127):20210448.
En savoir plus
Lysa
2021_LYSA_Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay
J Mol Diagn . 2021 Aug;23(8):929-940.
En savoir plus
Lysa
2021_LYSA_Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape
Immunity . 2021 Aug 10;54(8):1901.
En savoir plus
Lysa
2021_LYSA_New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT
Cancers (Basel) . 2021 Aug 8;13(16):3998.
En savoir plus
Lysa
2021_LYSA_Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming
J Clin Invest . 2021 Jul 1;131(13):e139675.
En savoir plus
Lysa
2021_LYSA_Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
Blood Cancer J . 2021 Jul 15;11(7):130.
En savoir plus